Favrille
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma Lymphoma | Phase 2 | 2004-09-01 |
| Unknown | Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma Lymphoma | Phase 2 | 2004-08-01 |
| Terminated | Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patien Lymphoma | Phase 3 | 2004-07-01 |
| Unknown | Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma | Phase 2 | 2002-07-01 |
| Unknown | Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma Lymphoma, Low-Grade | Phase 2 | 2001-03-01 |
| Suspended | GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in T Lymphoma | Phase 3 | — |